Discover trends, market shifts, and competitive outlooks for the branded generics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Branded Generics Market Expected to Grow Between 2025 And 2029?

The size of the branded generics market has seen a robust expansion in the recent past. It is expected to escalate from $363.49 billion in 2024 to $397.19 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. The factors propelling the growth during the previous period include cost-effectiveness and affordability, expiration of patents, growth in market availability and access, government actions and directives, and healthcare restructuring.

The market size for branded generics is poised for swift expansion in the coming years, with projections for a rise to $601.4 billion in 2029, representing a compound annual growth rate (CAGR) of 10.9%. This growth in the projected period is due to a surge in the demand for generic biologics, an increase in chronic diseases, the expansion of emerging markets, and a concentration on biosimilars. Strategic partnerships and collaborations, advancements in technology, focus on chronic diseases, market consolidation, and a patient-centered approach are expected to be the principal trends during the forecast period.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7186&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theBranded Generics Market?

The escalation in the incidence of chronic illnesses is anticipated to propel the growth of the branded generics market. Chronic illnesses are enduring ailments that often remain unhealed; however, they are manageable and treatable. The upsurge in the occurrence of these diseases is attributable to factors such as increased consumption of tobacco products, undernutrition, physical inactivity, excessive alcohol use, and so forth. Globally, customers are favoring branded generics for the management of chronic conditions due to their lower cost compared to regular medications. For example, the World Health Organization’s 2022 Highlights reported in September 2022 that noncommunicable diseases (NCDs) or chronic diseases caused 41 million deaths, representing 74% of all global deaths annually. This intergovernmental health organization, based in Switzerland, notes the significant role of such diseases. Thus, the rising prevalence of chronic diseases is likely to stimulate more demand for branded generics throughout the predicted period.

Which Segments in the Branded Generics Offer the Most Growth?

The branded generics market covered in this report is segmented –

1) By Drug Class: Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptics, Other Drugs

2) By Route Of Administration: Topical, Oral, Parenteral, Other Routes Of Administration

3) By Application: Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics And Anti-inflammatory, Other Applications

Subsegments:

1) By Alkylating Agents: Nitrogen Mustards, Ethylene Imine Compounds

2) By Antimetabolites: Purine Analogues, Pyrimidine Analogues

3) By Hormones: Corticosteroids, Thyroid Hormones

4) By Anti-Hypertensive: ACE Inhibitors, Beta Blockers, Calcium Channel Blockers

5) By Lipid Lowering Drugs: Statins, Fibrates

6) By Anti-Depressants: SSRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)

7) By Anti-Psychotics: Atypical Antipsychotics, Typical Antipsychotics

8) By Anti-Epileptics: Sodium Channel Blockers, GABAergic Drugs

9) By Other Drugs: Analgesics, Antibiotics, Antivirals

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7186&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theBranded Generics Market?# Market?

North America was the largest region in the branded generics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the branded generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Branded Generics Industry?

The trend of strategic alliance is pivotal in the branded generics market. Companies involved in branded generics are forming alliances with suitable businesses to maximize mutual resources and branch out into new market areas. For example, Biocon Ltd., a pharmaceutical firm based in India, entered into a partnership with Tabuk Pharmaceuticals in September 2024. Biocon has taken the responsibility of developing and producing GLP-1 products, ensuring top-quality biopharmaceuticals designed specifically for diabetes care. Meanwhile, Tabuk Pharmaceuticals has procured the rights to market authorization and will oversee the products’ registration, import, and promotion throughout the Middle East, especially in Saudi Arabia. The agreement also encompasses provisions for further expansion into other GLP products beyond the original offerings, enabling a wider spectrum of diabetes treatments. The alliance aims to provide unique health solutions that improve the health of patients in Saudi Arabia and adjacent regions, in line with both firms’ pledge to enhance access to healthcare. Tabuk Pharmaceuticals, based in Saudi Arabia, markets both branded and generic pharmaceutical products.

View the full report here:

https://www.thebusinessresearchcompany.com/report/branded-generics-global-market-report

What Are the Key Elements That Define the Branded Generics Market?

Branded generics refer to an unregistered drug that is marketed under a brand name and provides patients and healthcare providers with a benefit that encourages them to choose the brand. These are the generic medications that have a unique brand name on the market. They might be advertised similarly to how branded medications are.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7186

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model